Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

Share Price is delayed by 15 minutes
Get Live Data
133.40    1.80 (1.37%)
Bid:
133.20
Ask:
133.80
Spread: 0.60 (0.45%)
Market Cap: £272.52m
FORT Live PriceLast checked at - London Stock Exchange

Intraday Forterra Share Chart

Director/PDMR Shareholding

3 Dec 2019 07:00

RNS Number : 4152V
Forterra plc
03 December 2019
Β 

3 December 2019

Forterra plc (the "Company")

Director / PDMR Shareholdings

Following the maturity of the Forterra 2016 Save As You Earn Scheme (SAYE) on 1 December 2019, the Company was notified by the scheme's administrators, Link Group, of the following PDMR transactions. The PDMR's listed below exercised options over the share capital of the Company as follows:

Name

Role

Status

No. of options exercised

Exercise Price

Beneficial interest

% of ISC

Stephen Harrison

Chief Executive Officer

PDMR

13,333

Β£1.35

147,865

< 1%

Shatish Dasani

Chief Financial Officer

PDMR

13,333

Β£1.35

190,808

< 1%

Ben Guyatt

Director of Finance

PDMR

13,333

Β£1.35

37,757

< 1%

The exercise price of Β£1.35 was set upon the launch of the scheme in 2016 in line with HMRC rules.

Shatish Dasani immediately transferred 6,333 of his newly acquired shares to his wife, Mrs Dina Dasani.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Ben Guyatt (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

Β 

Β 

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Stephen Harrison

2.

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

Β 

GB00BYYW3C20

b)

Nature of the transaction

Exercise of share options with an exercise price of Β£1.35p under the Forterra SAYE scheme

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

Β Purchase

Β£1.35

Β 

Β 

13,333 options maturing

Β 

d)

Aggregated information

Β 

Transaction

Price(s)

Volume(s)

Total

Β Purchase

Β£1.35

13,333

Β£18,000

Β 

Β 

Β 

Β 

Β 

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Shatish Dasani

2.

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

Β 

GB00BYYW3C20

b)

Nature of the transaction

Exercise of share options with an exercise price of Β£1.35p under the Forterra SAYE scheme

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

Β Purchase

Β£1.35

Β 

Β 

13,333 options maturing

Β 

d)

Aggregated information

Β 

Transaction

Price(s)

Volume(s)

Total

Β Purchase

Β£1.35

13,333

Β£18,000

Β 

Β 

Β 

Β 

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ben Guyatt

2.

Reason for the notification

a)

Position/status

PDMR (Director of Finance and Company Secretary)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

Β 

GB00BYYW3C20

b)

Nature of the transaction

Exercise of share options with an exercise price of Β£1.35p under the Forterra SAYE scheme

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

Β Purchase

Β£1.35

Β 

Β 

13,333 options maturing

Β 

d)

Aggregated information

Β 

Transaction

Price(s)

Volume(s)

Total

Β Purchase

Β£1.35

13,333

Β£18,000

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHUGGCGPUPBPGP
Date   Source Headline
4th Nov 202410:24 amRNSHolding(s) in Company
30th Oct 20244:54 pmRNSHolding(s) in Company
28th Oct 202411:51 amRNSHolding(s) in Company
2nd Oct 20245:35 pmRNSGrant of Options under 2024 SAYE Scheme
11th Sep 20247:00 amRNSDirectorate Change
5th Sep 202411:49 amRNSHolding(s) in Company
2nd Sep 20249:59 amRNSHolding(s) in Company
12th Aug 20243:03 pmRNSHolding(s) in Company
30th Jul 20247:00 amRNSSix months ended 30 June 2024
14th Jun 202410:02 amRNSHolding(s) in Company
11th Jun 20244:45 pmRNSAnnual General Meeting 2024 Results - Replacement
10th Jun 202411:39 amRNSHolding(s) in Company
7th Jun 202410:50 amRNSHolding(s) in Company
6th Jun 20243:38 pmRNSDirector/PDMR Shareholding
6th Jun 20243:34 pmRNSDirector/PDMR Shareholding
31st May 20248:12 amRNSDirector/PDMR Shareholding
21st May 20244:39 pmRNSAnnual General Meeting 2024 Results
21st May 20249:00 amRNSDirector/PDMR Shareholding
21st May 20247:50 amRNSProgressive publishes new research
21st May 20247:00 amRNS2024 AGM Trading Update
14th May 202411:44 amRNSHolding(s) in Company
2nd May 202410:46 amRNSGrant under Performance Share Plan
15th Apr 20241:46 pmRNSAnnual Report & Accounts 2023 & Notice of AGM 2024
12th Apr 202412:09 pmRNSDirector/PDMR Shareholding
9th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20244:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20242:19 pmRNSDirector/PDMR Shareholding
27th Mar 20244:44 pmRNSDirector/PDMR Shareholding
25th Jan 202412:27 pmRNSDirector Declaration
24th Jan 20247:19 amRNSProgressive publish new research
24th Jan 20247:00 amRNS2023 Trading Update
23rd Jan 20247:00 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSDirector Declaration
9th Nov 20237:00 amRNSAppointment of Joint Corporate Broker
20th Oct 20236:05 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSQ3 Trading Update
5th Oct 20235:04 pmRNSGrant of Options under 2023 SAYE Scheme
11th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20235:46 pmRNSHolding(s) in Company
23rd Aug 20233:59 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSSix months ended 30 June 2023
11th Jul 20237:00 amRNSPost close half year trading update
5th Jul 202312:39 pmRNSEmployee Benefit Trust Share Purchase
30th Jun 20231:51 pmRNSHolding(s) in Company
6th Jun 202312:57 pmRNSEmployee Benefit Trust Share Purchase
23rd May 20232:22 pmRNSAnnual General Meeting 2023 Results
18th May 202312:12 pmRNSProgressive publish new research
16th May 20237:00 amRNSPre-AGM trading update
5th May 20234:39 pmRNSDirector/PDMR Shareholding
4th May 20239:00 amRNSEmployee Benefit Trust Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.